Association of frailty with in-hospital outcomes in elderly patients with heart failure

doi:10.12998/wjcc.v9.i36.11208

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 36

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3369)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-5) series.

Item

Count

PDF

268

WORD

106

HTML

1841

Figures (1-1)

143

Tables (1-5)

165

Sum=2523

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

261

Download

585

Sum=846

Dec 26, 2021 (publication date) through Nov 22, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Clin Cases. Dec 26, 2021; 9(36): 11208-11219
Published online Dec 26, 2021. doi: 10.12998/wjcc.v9.i36.11208

Table 1 Characteristics of the included elderly patients with heart failure and reduced ejection according to the frailty status

	Frail (n = 135)	Pre-frail (n = 93)	P value
Demographic factors
Age (yr)	70.7 ± 7.2	68.8 ± 5.8	0.039
Female, n (%)	44 (32.6)	25 (26.9)	0.022
NYHA Class
III, n (%)	70 (51.9)	57 (61.3)	0.249
IV, n (%)	44 (32.6)	23 (24.7)	0.010
Medical history
Hypertension, n (%)	78 (57.8)	48 (51.6)	0.358
DM, n (%)	57 (42.2)	29 (31.2)	0.091
Dyslipidemia, n (%)	34 (25.2)	17 (18.3)	0.219
AF, n (%)	40 (29.6)	18 (19.4)	0.080
PAD, n (%)	9 (6.7)	8 (8.6)	0.585
CABG, n (%)	15 (11.1)	11 (11.8)	0.867
PCI, n (%)	24 (17.8)	18 (19.4)	0.763
Clinical parameters
SBP (mmHg)	107.71 ± 21.03	114.01 ± 23.39	0.035
DBP (mmHg)	66.90 ± 13.57	72.03 ± 12.06	0.004
HR (bpm)	88.16 ± 20.41	89.39 ± 19.77	0.653
ALT (U/L)¹	39 (23, 79)	35 (20, 71)	0.347
SCr (μmol/L)	109.70 ± 65.63	102.67 ± 54.03	0.395
FPG (mmol/L)	9.01 ± 6.32	8.49 ± 4.18	0.499
TG (mmol/L)¹	1.4 (0.9, 1.8)	1.5 (1.0, 2.1)	0.082
LDL-C (mmol/L)	2.59 ± 0.77	3.44 ± 1.51	0.455
HDL-C (mmol/L)	1.05 ± 0.31	0.99 ± 0.31	0.901
PaO₂ (mmHg)	96.85 ± 33.03	101.12 ± 38.93	0.374
BNP (μmol/L)¹	712 (329, 1422)	542 (307, 925)	0.189
Echocardiography
LVEDD (mm)	56.81 ± 9.01	54.46 ± 7.66	0.036
LVESD (mm)	41.97 ± 11.03	41.89 ± 9.98	0.956
LVEF (%)	33.79 ± 6.06	34.03 ± 5.64	0.753
LV thrombosis, n (%)	27 (20)	9 (9.7)	0.036
Medications
Diuretics, n (%)	101 (74.8)	73 (78.5)	0.521
ARAs, n (%)	90 (66.7)	55 (59.1)	0.246
ACEIs/ARBs, n (%)	75 (55.6)	53 (57.0)	0.830
Beta-blockers, n (%)	114 (84.4)	76(81.7)	0.588
Digitalis, n (%)	51 (37.8)	23 (24.7)	0.039
Anticoagulants, n (%)	65 (48.1)	33 (35.5)	0.058

¹Data are presented as medians and interquartile ranges.

NYHA: New York Heart Association; DM: Diabetes mellitus; AF: Atrial fibrillation; PAD: Peripheral artery disease; CABG: Coronary artery bypass grafting; PCI: Percutaneous coronary intervention; SBP: Systolic blood pressure; DBP: Diastolic blood pressure; HR: Heart rate; ALT: Alanine aminotransferase; SCr: Serum creatinine; FPG: Fasting plasma glucose; TG: Triglyceride; LDL-C: Low-density lipoprotein cholesterol; HDL-C: High-density lipoprotein cholesterol; BNP: Type B natriuretic peptide; LVEDD: Left ventricular end-diastolic dimension; LVESD: Left ventricular end-systolic dimension; LVEF: Left ventricular ejection fraction; LV: Left ventricular; ARAs: Aldosterone Receptor Antagonists; ACEIs: Angiotensin converting enzyme inhibitors; ARBs: Angiotensin II receptor blockers.

Table 2 Physical performance of the included patients evaluated by short physical performance battery according to the frailty status (mean ± SD)

	Frail (n = 135)	Pre-frail (n = 93)	P value
Handgrip strength (kg)
Men	23.8 ± 4.1	25.1 ± 4.2	0.056
Women	17.9 ± 3.4	21.2 ± 4.5	0.003
Balance test	3.08 ± 0.68	3.42 ± 0.61	< 0.001
Four-meter gait test	2.19 ± 0.82	2.70 ± 0.76	< 0.001
Chair stand test	1.96 ± 0.77	2.83 ± 0.70	< 0.001
Overall SPPB score	7.24 ± 1.72	8.95 ± 1.44	< 0.001

SPPB: Short physical performance battery; SDs: Standard deviations.

Table 3 Incidence of in-hospital mortality and the major causes of mortality during hospitalization according to the frailty status of the patients

	Frail (n = 135)	Pre-frail (n = 93)	P value
In-hospital death	16 (11.9)	4 (4.3)	0.048
Cardiac shock	3 (2.2)	2 (2.4)	0.971
Malignant arrhythmia	3 (2.2)	1 (1.1)	0.517
MOF	10 (7.4)	1 (1.1)	0.028

MOF: Multiple organ failure.

Table 4 Patient characteristics and the composite outcome of in-hospital adverse events: Results of univariate analysis

	With AEs (n = 86)	Without AEs (n = 142)	P value
Female, n (%)	30 (34.9)	39 (27.5)	0.279
NYHA Class III/IV, n (%)	79 (91.9)	115 (80.9)	0.010
Frailty, n (%)	62 (72.1)	73 (51.4)	0.002
Hypertension, n (%)	54 (62.8)	72 (50.7)	0.075
DM, n (%)	33 (38.4)	53 (37.3)	0.874
Dyslipidemia, n (%)	18 (20.9)	33 (23.2)	0.685
AF, n (%)	28 (32.6)	30 (21.1)	0.055
Age (yr)	72.05 ± 7.46	68.65 ± 5.90	< 0.001
Handgrip strength (kg)	22.26 ± 5.34	23.04 ± 4.44	0.030
Overall SPPB score	7.50 ± 2.04	8.18 ± 1.61	0.006
SBP (mmHg)	110.87 ± 23.24	109.92 ± 21.62	0.759
DBP (mmHg)	69.34±15.13	68.78 ± 11.92	0.772
PaO₂ (mmHg)	99.23 ± 47.56	98.20 ± 25.87	0.853
LVEF (%)	33.74 ± 6.45	33.97 ± 5.53	0.786

AEs: Adverse events; NYHA: New York Heart Association; DM: Diabetes mellitus; AF: Atrial fibrillation; SPPB: Short physical performance battery; SBP: Systolic blood pressure; DBP: Diastolic blood pressure; LVEF: Left ventricular ejection fraction; LV: Left ventricular.

Table 5 Potential predictive efficacy of frailty on the composite outcome of in-hospital adverse events: results of multivariate logistic regression analysis

	SE	OR	95%CI	P value
Female	0.410	0.422	0.189-0.943	0.035
Age	0.029	1.090	1.029-1.154	0.003
NYHA Class III/IV	0.253	2.167	1.320-3.559	0.002
Frailty	0.351	2.379	1.196-4.733	0.014
Overall SPPB Score	0.100	0.945	0.776-1.150	0.570
Handgrip strength	0.047	1.106	1.010-1.212	0.030
SBP	0.007	1.003	0.989-1.017	0.656
LVEF	0.027	0.990	0.939-1.042	0.694

SE: Standard error; OR: Odds ratio; CI: Confidence interval; AEs: Adverse events; SPPB: Short physical performance battery; SBP: Systolic blood pressure; LVEF: Left ventricular ejection fraction.

Citation: Kang YP, Chen LY, Zhu JJ, Liu WX, Ma CS. Association of frailty with in-hospital outcomes in elderly patients with heart failure. World J Clin Cases 2021; 9(36): 11208-11219
URL: https://www.wjgnet.com/2307-8960/full/v9/i36/11208.htm
DOI: https://dx.doi.org/10.12998/wjcc.v9.i36.11208